GEODE CAPITAL MANAGEMENT, LLC

Holdings History for Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share (AVDL)

Symbol: AVDL on Nasdaq
Investment type: Equity / American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Jun 2024		-0%	$0	0	-104,227	-100%	$18.78	Q2 2024
31 Mar 2024	0%	+0%	$1,760,394	104,227	+11,644	+13%	$16.89	Q1 2024
31 Dec 2023	0%	-0%	$1,307,271	92,583	-1,822	-1.9%	$14.12	Q4 2023
30 Sep 2023	0%	+0%	$972,371	94,405	+14,003	+17%	$10.30	Q3 2023
30 Jun 2023	0%	+0%	$1,325,024	80,402	+399	+0.5%	$16.48	Q2 2023
31 Mar 2023	0%	+0%	$732,827	80,003	+924	+1.2%	$9.16	Q1 2023
31 Dec 2022	0%	+0%	$566,000	79,079	+38,551	+95%	$7.16	Q4 2022
30 Sep 2022	0%	0%	$203,000	40,528	0		$5.01	Q3 2022
30 Jun 2022	0%	0%	$98,000	40,528	0		$2.42	Q2 2022
31 Mar 2022	0%	0%	$276,000	40,528	0		$6.81	Q1 2022
31 Dec 2021	0%	0%	$327,000	40,528	0		$8.07	Q4 2021
30 Sep 2021	0%	0%	$397,000	40,528	0		$9.80	Q3 2021
30 Jun 2021	0%	-0%	$272,000	40,528	-1,917	-4.5%	$6.71	Q2 2021
31 Mar 2021	0%	+0%	$383,000	42,445	+7,893	+23%	$9.02	Q1 2021
31 Dec 2020	0%	0%	$230,000	34,552	0		$6.66	Q4 2020
30 Sep 2020	0%	+0%	$174,000	34,552	+7,157	+26%	$5.04	Q3 2020
30 Jun 2020	0%	+0%	$221,000	27,395	+1,282	+4.9%	$8.07	Q2 2020
31 Mar 2020	0%	-0%	$207,000	26,113	-20,107	-44%	$7.93	Q1 2020
31 Dec 2019	0%	0%	$348,000	46,220	0		$7.53	Q4 2019
30 Sep 2019	0%	0%	$192,000	46,220	0		$4.15	Q3 2019
30 Jun 2019	0%	+0%	$133,000	46,220	+9,221	+25%	$2.88	Q2 2019
31 Mar 2019	0%	0%	$53,000	36,999	0		$1.43	Q1 2019
31 Dec 2018	0%	0%	$95,000	36,999	0		$2.57	Q4 2018
30 Sep 2018	0%	0%	$162,000	36,999	0		$4.38	Q3 2018
30 Jun 2018	0%	+0%	$226,000	36,999	+24,319	+192%	$6.11	Q2 2018
31 Mar 2018	0%	0%	$92,000	12,680	0		$7.26	Q1 2018
31 Dec 2017	0%	-0%	$103,000	12,680	-9,372	-42%	$8.12	Q4 2017
30 Sep 2017	0%	-0%	$231,000	22,052	-11,274	-34%	$10.48	Q3 2017
30 Jun 2017	0%	+0%	$367,000	33,326	+2,063	+6.6%	$11.01	Q2 2017
31 Mar 2017	0%	+0%	$302,000	31,263	+31,263	NEW	$9.66	Q1 2017

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.